Reversible Drug-Induced Pisa Syndrome Due to a Cholinesterase Inhibitor

Affiliations

Arnout Bruggeman et al. Mov Disord Clin Pract. 2021.

. 2021 Jun 4;8(6):961-962.

doi: 10.1002/mdc3.13253. eCollection 2021 Aug.

No abstract available

Keywords: Pisa syndrome; cholinesterase inhibitors; drug‐induced; posture.

Conflict of interest statement

No specific funding was received for this work. The authors declare that there are no conflicts of interest relevant to this work.

1. Tinazzi M, Geroin C, Gandolfi M, et al. Pisa syndrome in Parkinson's disease: an integrated approach from pathophysiology to management. Mov Disord 2016;31:1785–1795. - PubMed
1. Castrioto A, Piscicelli C, Pérennou D, Krack P, Debû B. The pathogenesis of Pisa syndrome in Parkinson's disease. Mov Disord 2014;29:1100–1107. - PubMed
1. Mimura Y, Kurose S, Takata T, Tabuchi H, Mimura M, Funayama M. Pisa syndrome induced by switching of a choline‐esterase inhibitor treatment from donepezil to galantamine: a case report. BMC Neurol 2020;20:183. - PMC - PubMed
1. Zannas AS, Okuno Y, Doraiswamy PM. Cholinesterase inhibitors and Pisa syndrome: a pharmacovigilance study. Pharmacotherapy 2013;34:272–278. - PubMed
1. Bhattacharya KF, Giannakikou I, Munroe N, Chaudhuri KR. Primary anticholinergic‐responsive Pisa syndrome. Mov Disord 2000;15:1285–1287. - PubMed